D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 60 Citations 22,000 228 World Ranking 5316 National Ranking 99

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Enzyme

The scientist’s investigation covers issues in PI3K/AKT/mTOR pathway, Protein kinase B, Cancer research, Cell biology and Signal transduction. His studies deal with areas such as Autophagy, Targeted therapy, Leukemia and Cell growth as well as PI3K/AKT/mTOR pathway. The various areas that he examines in his Autophagy study include Computational biology and Physiology.

His work carried out in the field of Protein kinase B brings together such families of science as Jurkat cells, Cellular differentiation, GSK-3, Internal medicine and Pharmacology. His research in Cancer research intersects with topics in Cancer, Kinase, MAPK/ERK pathway, Immunology and PTEN. Within one scientific family, Alberto M. Martelli focuses on topics pertaining to Nuclear protein under Cell biology, and may sometimes address concerns connected to Nuclear matrix.

His most cited work include:

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
  • Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health (423 citations)
  • Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging (416 citations)

What are the main themes of his work throughout his whole career to date?

Alberto M. Martelli mainly investigates Cancer research, Protein kinase B, PI3K/AKT/mTOR pathway, Cell biology and Signal transduction. His Cancer research research is multidisciplinary, relying on both Cancer, Targeted therapy, Leukemia, Immunology and MAPK/ERK pathway. His Protein kinase B research integrates issues from Jurkat cells, Internal medicine and Kinase.

His PI3K/AKT/mTOR pathway research includes elements of Pharmacology and Cell growth. He has researched Cell biology in several fields, including Molecular biology and Biochemistry. His study in Signal transduction is interdisciplinary in nature, drawing from both Cellular differentiation and DNA repair.

He most often published in these fields:

  • Cancer research (47.54%)
  • Protein kinase B (39.34%)
  • PI3K/AKT/mTOR pathway (36.39%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cancer research (47.54%)
  • Signal transduction (24.26%)
  • Cancer (10.16%)

In recent papers he was focusing on the following fields of study:

Alberto M. Martelli spends much of his time researching Cancer research, Signal transduction, Cancer, PI3K/AKT/mTOR pathway and Protein kinase B. His Cancer research research is multidisciplinary, incorporating perspectives in Pancreatic cancer, Cancer cell, Targeted therapy, Leukemia and MAPK/ERK pathway. His Signal transduction study results in a more complete grasp of Cell biology.

Alberto M. Martelli has included themes like Inducer, Caspase and Protein family in his Cell biology study. Alberto M. Martelli interconnects mTORC1, Radiosensitivity, Disease and Doxorubicin in the investigation of issues within Cancer. The Protein kinase B study combines topics in areas such as Wnt signaling pathway, Cytotoxic T cell, Receptor and PTEN.

Between 2016 and 2021, his most popular works were:

  • Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. (116 citations)
  • Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. (86 citations)
  • Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells. (44 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Enzyme

Alberto M. Martelli mainly focuses on Cancer research, microRNA, Resveratrol, PI3K/AKT/mTOR pathway and Protein kinase B. His Cancer research research includes themes of Cancer, Gemcitabine, Gene, Hedgehog signaling pathway and Leukemia. His biological study spans a wide range of topics, including Carcinogenesis, Tumor suppressor gene, Cancer stem cell, Internal medicine and Tumor progression.

His Carcinogenesis study integrates concerns from other disciplines, such as Cell cycle, Bcl-2-associated X protein, Mdm2 and Cell biology. His work in Resveratrol addresses issues such as Nutraceutical, which are connected to fields such as Inflammation, Antioxidant, Oxidative stress, Metformin and Cancer cell. His PI3K/AKT/mTOR pathway study focuses mostly on Mechanistic target of rapamycin, mTORC1 and PTEN.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)

7788 Citations

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)

4781 Citations

Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

Linda S. Steelman;William H. Chappell;Stephen L. Abrams;C. Ruth Kempf.
Aging (Albany NY) (2011)

654 Citations

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health

William H. Chappell;Linda S. Steelman;Jacquelyn M. Long;Ruth C. Kempf.
Oncotarget (2011)

564 Citations

Nuclear localization and signalling activity of phosphoinositidase Cβ in Swiss 3T3 cells

Alberto M. Martelli;R. Stewart Gilmour;Valeria Bertagnolo;Luca M. Neri.
Nature (1992)

450 Citations

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia

L. S. Steelman;S. L. Abrams;J. Whelan;F. E. Bertrand.
Leukemia (2008)

401 Citations

GSK-3 as potential target for therapeutic intervention in cancer.

James A. McCubrey;Linda S. Steelman;Fred E. Bertrand;Nicole Marie Davis.
Oncotarget (2014)

399 Citations

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance

James Andrew McCubrey;Linda S. Steelman;William H. Chappell;Stephen L. Abrams.
Oncotarget (2012)

310 Citations

Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mtor cascades which alter therapy response

James A McCubrey;Linda S Steelman;William H Chappell;Stephen L Abrams.
Oncotarget (2012)

300 Citations

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.

Alberto M. Martelli;Camilla Evangelisti;Francesca Chiarini;James A. McCubrey.
Oncotarget (2010)

273 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alberto M. Martelli

Lucio Cocco

Lucio Cocco

University of Bologna

Publications: 130

James A. McCubrey

James A. McCubrey

East Carolina University

Publications: 89

Luca M. Neri

Luca M. Neri

University of Ferrara

Publications: 58

Silvano Capitani

Silvano Capitani

University of Ferrara

Publications: 57

Daniel J. Klionsky

Daniel J. Klionsky

University of Michigan–Ann Arbor

Publications: 33

Nadir M. Maraldi

Nadir M. Maraldi

National Academies of Sciences, Engineering, and Medicine

Publications: 33

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 31

Sergio Lavandero

Sergio Lavandero

University of Chile

Publications: 28

Saeid Ghavami

Saeid Ghavami

University of Manitoba

Publications: 28

Pann-Ghill Suh

Pann-Ghill Suh

Korea Brain Research Institute

Publications: 28

Leonidas C. Platanias

Leonidas C. Platanias

Northwestern University

Publications: 25

Patrice Codogno

Patrice Codogno

Université Paris Cité

Publications: 25

Øystein Bruserud

Øystein Bruserud

University of Bergen

Publications: 25

Nullin Divecha

Nullin Divecha

University of Southampton

Publications: 24

Ciro Isidoro

Ciro Isidoro

University of Eastern Piedmont Amadeo Avogadro

Publications: 21

Marina Konopleva

Marina Konopleva

The University of Texas MD Anderson Cancer Center

Publications: 20

Trending Scientists

Franz Baader

Franz Baader

TU Dresden

Andrew Johnson

Andrew Johnson

University of Illinois at Chicago

Elaine J. Weyuker

Elaine J. Weyuker

University of Central Florida

James Andreoni

James Andreoni

University of California, San Diego

Andrés Velasco

Andrés Velasco

London School of Economics and Political Science

Rami Haj-Ali

Rami Haj-Ali

Tel Aviv University

Sidney W. Benson

Sidney W. Benson

SRI International

Guang-Hui Liu

Guang-Hui Liu

Chinese Academy of Sciences

Andrew W. B. Johnston

Andrew W. B. Johnston

University of East Anglia

Páll Einarsson

Páll Einarsson

University of Iceland

Michael P. O'Driscoll

Michael P. O'Driscoll

University of Waikato

Erik J. Bergstralh

Erik J. Bergstralh

Mayo Clinic

Lisa M. Powell

Lisa M. Powell

University of Illinois at Chicago

Erik H. Erikson

Erik H. Erikson

Harvard University

Gary M. Segura

Gary M. Segura

Stanford University

Itziar Aretxaga

Itziar Aretxaga

National Institute of Astrophysics, Optics and Electronics

Something went wrong. Please try again later.